Organic Nanoparticles Emerge as Safer Rivals to Inorganic Theranostic Platforms
A new review argues that organic and hybrid nanomaterials can match or exceed the diagnostic and therapeutic performance of inorganic ...
A new review argues that organic and hybrid nanomaterials can match or exceed the diagnostic and therapeutic performance of inorganic ...
A new Frontiers in Nuclear Medicine review proposes an evidence-gated framework that separates established PSMA and somatostatin receptor theranostics from ...
Six ahead-of-print studies in The Journal of Nuclear Medicine report PET tracking of radiolabeled trastuzumab deruxtecan in preclinical tumors, astatine-211 ...
A scoping review of 38 studies maps the evidence for ultrasound-triggered microbubble and nanobubble platforms in breast cancer imaging, local ...
A 2026 editorial describes preclinical and review evidence on lung scaffolds, conductive diabetic-wound hydrogels, extracellular vesicles and liver-targeted nanoparticles while ...
A small retrospective study found that FAP-targeted BED003-PET detected more recurrent or metastatic medullary thyroid carcinoma lesions than DOPA-PET, while ...
A new review in Pharmacia charts how magnetic nanoparticles, metal-organic frameworks, and ROS-responsive carriers are transforming targeted cancer therapy and ...
Seven new ahead-of-print studies in The Journal of Nuclear Medicine report advances in prostate cancer theranostics, AI survival prediction, radiopharmaceutical ...
A systematic review of all 54 African nations finds radionuclide cancer therapies available in only a fraction of countries, while ...
A new review highlights how chitosan and hyaluronic acid nanoparticles are being engineered into multifunctional platforms that combine photothermal therapy, ...
A systematic review finds that nanoparticles conjugated with fibroblast activation protein inhibitors show strong preclinical promise for targeted cancer imaging ...
A systematic review finds that quantitative bone SPECT/CT can objectively measure skeletal radiotracer uptake for cancer and benign disease, but ...
A new review of preclinical evidence shows that precision-engineered nanocarriers, from platelet-hitchhiking cancer drugs to brain-penetrating siRNA particles, are transforming ...
A comprehensive evidence map of 73 AI studies across radiopharmaceutical therapy finds impressive technical progress in segmentation, dosimetry, and prediction ...
A new review outlines how immunomodulation and immunoengineering, from extracellular vesicles and stem cells to smart theranostic dressings, could reset ...
Researchers have engineered salamander-inspired gold-silver nanocages that cascade-target injured kidney cells and their mitochondria, delivering the antioxidant idebenone while enabling ...
Researchers have engineered manganese dioxide nanocarriers that degrade inside the tumor microenvironment to release methotrexate and activate DNAzyme probes, achieving ...
New ahead-of-print studies in The Journal of Nuclear Medicine describe advances in prostate cancer theranostics, enzyme-enhanced tumor imaging, novel PET ...
Researchers combined anti-PD-L1 immunotherapy with the PARP inhibitor Olaparib to trigger ferroptosis in liver cancer and used the SLC7A11-targeted PET ...
A new Journal of Nuclear Medicine supplement surveys the theranostics pipeline, from isotope supply and dosimetry to pivotal phase 3 ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.